Help us make better tools for you!. Read more (Published: 2017-01-12)

ALXN - Alexion Pharmaceuticals Tue 24'th Jan 2017

Industry: Biotechnology Sector: Healthcare
Add to Watchlist


Score: 0.75

#3548 of 5186
MV Long:
MV Short:
Accuracy: 91.89%
Risk: Medium
Request Prediction
We need your help. Please answer this short survey to help us improve by clicking HERE.

Stock analysis for Tue 24'th Jan 2017 (Updated daily)

Hold candidate since 2017-01-23

Loss -1.23%

Alexion Pharmaceuticals Stock Analysis

Alexion Pharmaceuticals fell by -1.23% in the last day, from USD 131.49 to USD 129.87. , and has now fallen 5 day in a row The price has fallen in 8 of the last 10 days and is down by -10.29% for this period. Volume increased in the last day by 0.08 million shares, but on falling prices. This is may be an early warning and risk is increased slightly for the next couple of days. In total, 1.63 million shares bought and sold for approximately USD 212 million.


Alexion Pharmaceuticals lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.7% during the next 3 months and, with 90% probability hold a price between USD 123.48 and USD 156.74 at the end of this period.


Alexion Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately USD 133.68. On a fall, the stock will find some support from the long-term average at approximately USD 127.45. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Tuesday December 13, 2016, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Relative Strength Index (RSI)

RSI14 is 59 and the stock is currently not being overbought or oversold

Support & Resistance

Alexion Pharmaceuticals finds support from accumulated volume at USD 129.00, USD 126.88, and USD 115.08. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 131.37, USD 136.66 and USD 139.18.

The stock is about to test the resistance from accumulated volume at USD 131.37 and this may cause the stock to take a minor break or get into a more sideways move for a few days.


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 3.15 between high and low, or 2.44%. For the last week, the stock has had a daily average volatility of 2.60%.

Our recommended stoploss: USD 123.87 (-4.62%) ( criteria: risk and position in trend)


Alexion Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend a hold or accumulate position awaiting further development.


Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Chart Explanation

Build Your Watchlist

Add ALXN My Watchlist

Weekly Trading Secrets

book of the week

Companies analyzed today